Table 5

Acetaminophen use and NSAID use 1 day or more per week and 4 days or more per week for at least 6 months among 485 cases of metastatic epithelial ovarian cancer and 295 cases of nonmetastatic epithelial ovarian cancera

UseCasesORb (95% CI)
Cancer controlsNoncancer controls
Metastatic ovarian cancer
Acetaminophen
1+ days/weekNo466Ref.Ref.
1+ days/weekYes180.9 (0.5–1.5)1.0 (0.6–1.7)
4+ days/weekNo477Ref.Ref.
4+ days/weekYes70.4 (0.2–1.2)0.7 (0.3–1.6)
NSAIDs
1+ days/weekNo445Ref.Ref.
1+ days/weekYes340.7 (0.5–1.0)0.6 (0.4–0.9)
4+ days/weekNo458Ref.Ref.
4+ days/weekYes220.5 (0.3–0.8)0.5 (0.3–0.8)
Nonmetastatic ovarian cancer
Acetaminophen
1+ days/weekNo284Ref.Ref.
1+ days/weekYes100.9 (0.4–1.8)1.0 (0.5–1.9)
4+ days/weekNo288Ref.Ref.
4+ days/weekYes71.0 (0.4–2.3)1.3 (0.6–3.0)
NSAIDs
1+ days/weekNo270Ref.Ref.
1+ days/weekYes241.0 (0.6–1.6)0.9 (0.6–1.4)
4+ days/weekYes275Ref.Ref.
4+ days/weekYes190.9 (0.6–1.6)0.9 (0.6–1.6)
  • a Women whose only use began within the year before admission are excluded.

  • b OR, odds ratio from logistic regressions with terms for age, geography, and interview year.